No single pill or habit reverses aging entirely, but several interventions have measurably reduced biological age in human studies. The most promising approaches target the root mechanisms that make cells and tissues deteriorate over time: accumulated cellular damage, chronic inflammation, metabolic dysfunction, and the buildup of malfunctioning cells. Some of these interventions are available now, others are still experimental, and the strength of evidence varies widely.
Why the Body Ages in the First Place
Aging isn’t one process. It’s at least nine interlocking ones, each feeding into the others. A landmark 2013 paper in the journal Cell grouped them into three tiers. The primary drivers are straightforwardly destructive: DNA damage accumulates, the protective caps on chromosomes (telomeres) shorten, the chemical tags that control gene expression drift out of place, and the cell’s protein-recycling machinery breaks down.
A second tier involves systems that are helpful in small doses but harmful when they become chronic. Cellular senescence, for example, is a defense mechanism where damaged cells stop dividing to prevent cancer. But over decades, these “zombie cells” pile up and pump out inflammatory signals that damage surrounding tissue. Similarly, the body’s nutrient-sensing pathways promote growth when you’re young but accelerate wear and tear when they stay switched on in later life.
The third tier is where the damage becomes visible. Stem cells lose their ability to replenish tissues, and communication between cells breaks down, leading to chronic low-grade inflammation. Any strategy that genuinely reverses aging has to address one or more of these root causes, not just smooth out surface symptoms.
Clearing Zombie Cells With Senolytics
Senolytic drugs selectively kill senescent cells, the damaged cells that refuse to die and instead secrete a cocktail of inflammatory molecules. In naturally aged mice, clearing these cells improved heart function, blood vessel health, and treadmill endurance, and reduced frailty.
The first human evidence came from a small pilot study in patients with diabetic kidney disease. Nine participants (average age 69) took a three-day oral course of a senolytic combination. Within 11 days, senescent cell counts dropped in both fat tissue and skin, and several inflammatory blood markers, including IL-1α, IL-6, and specific tissue-degrading enzymes, decreased. A separate trial in patients with idiopathic pulmonary fibrosis found that the same drug combination improved physical function. These are early, small studies with no placebo control, but the direction of the results is consistent with the animal data. Larger randomized trials are underway.
Slowing the Growth Pathway With Rapamycin
One of the most replicated findings in longevity research is that dialing down the body’s growth-signaling network extends lifespan in nearly every organism tested. Rapamycin, a drug originally used to prevent organ transplant rejection, does exactly this by inhibiting a central growth regulator called mTOR.
In healthy elderly humans, chronic low-dose treatment with rapamycin or a closely related compound did not cause the blood sugar problems sometimes seen at high doses in cancer patients. In fact, the risk of elevated blood sugar was lower in the treatment group than in the placebo group. For potential anti-aging use, researchers have proposed intermittent dosing, such as once a week, to minimize side effects like mouth sores or mild blood count changes. This approach remains off-label and experimental, but the biological rationale is among the strongest in the longevity field.
Fasting and Fasting-Mimicking Diets
Caloric restriction activates autophagy, the process by which cells break down and recycle damaged components. You don’t need to starve yourself to trigger it. A fasting-mimicking diet, which involves eating a reduced-calorie, plant-based menu for five consecutive days per month while eating normally the rest of the time, has shown measurable results in a clinical trial published in Nature Communications. After three monthly cycles, participants showed a median decrease of 2.5 years in biological age, as measured by a validated predictor of disease risk and mortality. That reduction was independent of weight loss, suggesting the benefit comes from the metabolic reset itself rather than simply losing fat.
Exercise and Cardiorespiratory Fitness
Cardiorespiratory fitness, often measured by VO2 max, is one of the strongest predictors of how long you’ll live. A large study found that people who rated their physical fitness as poor had roughly 1.9 times the risk of dying from any cause compared to fitter individuals. That’s a bigger risk difference than many people realize, putting low fitness in the same ballpark as smoking or high blood pressure as a mortality risk factor.
Exercise works on multiple hallmarks of aging simultaneously. It stimulates autophagy, reduces chronic inflammation, improves mitochondrial function, and helps maintain stem cell activity in muscles and other tissues. Both aerobic exercise and resistance training contribute, and the benefits scale with intensity. High-intensity interval training appears particularly effective at boosting mitochondrial function in older adults, essentially making the cell’s energy-producing machinery work more like it did years earlier.
NAD+ Precursors: Popular but Uncertain
NAD+ is a molecule every cell needs to produce energy and repair DNA. Its levels decline with age, which has made supplements that boost NAD+ enormously popular. The two main options are NMN and NR.
A randomized, double-blind trial gave 80 healthy middle-aged adults either a placebo or NMN at doses of 300, 600, or 900 mg daily for 60 days. The results were underwhelming: there were no statistically significant differences in insulin resistance between any NMN group and placebo. Walking endurance and general health scores were also measured, but the headline finding is that the metabolic improvements many supplement companies promise haven’t materialized in rigorous human trials. NAD+ precursors do raise NAD+ levels in the blood, but whether that translates into meaningful anti-aging benefits remains unproven.
Epigenetic Reprogramming
The most ambitious approach to reversing aging involves reprogramming cells at the epigenetic level, resetting the chemical tags on DNA that drift out of place over a lifetime. This builds on the Nobel Prize-winning discovery of four proteins (called Yamanaka factors) that can turn an adult cell back into a stem cell. The trick is to apply them briefly, enough to rejuvenate the cell without erasing its identity entirely.
Partial reprogramming has already enhanced the function of human muscle stem cells, reversed aging-related gene expression patterns in mouse tissues, and turned back the epigenetic clock in human skin cells in the lab. But the technology has serious safety hurdles. Pushing cells too far toward a stem-cell state risks tumor formation, and current delivery methods can’t target specific organs precisely enough for clinical use. Direct editing of human DNA to install these reprogramming factors is prohibited for safety and ethical reasons. This is likely a decade or more from becoming a therapy, but it represents the most direct attack on the root cause of aging that science has produced.
Turning Back the Epigenetic Clock With Hormones
The TRIIM trial made headlines by showing that a combination of growth hormone and two other compounds could reverse epigenetic aging in a small group of men. After 12 months of treatment, participants’ biological age (measured by epigenetic clocks on DNA) decreased by about 2.5 years compared to no treatment. Even six months after stopping the intervention, a separate epigenetic predictor of disease risk still showed roughly a 2-year improvement. The trial also reversed age-related decline in the thymus, the gland that produces immune cells. These results are from a small, uncontrolled study, so they need replication, but they were the first demonstration that epigenetic age can be reversed in living humans.
Plasma Exchange
Therapeutic plasma exchange, which filters and replaces the liquid portion of blood, has shown surprisingly broad effects on aging biomarkers. In a randomized, placebo-controlled trial, biweekly plasma exchange combined with an infusion of immune proteins proved most effective, reversing age-related immune decline and reducing proteins linked to chronic inflammation. Across 15 different epigenetic clocks, a tool that estimates biological age from DNA patterns, the treatment group showed significant rejuvenation compared to placebo. The mechanism likely involves removing accumulated inflammatory and pro-aging factors from the bloodstream, giving tissues a cleaner environment in which to function.
What Actually Matters Right Now
The interventions with the strongest evidence you can act on today are exercise, periodic fasting or fasting-mimicking diets, and maintaining a healthy body composition. These target multiple hallmarks of aging at once and have decades of supporting data. Senolytics, rapamycin, and plasma exchange are generating compelling early results but remain experimental. NAD+ supplements are widely marketed but have yet to show clear anti-aging benefits in controlled human trials. And full cellular reprogramming, while theoretically the most powerful approach, is still confined to the lab. The field is moving fast, but the basics still outperform the cutting edge for most people.